Diriba, Mollalign et al., use whole-genome sequencing to investigate drug resistance mutations in extensively drug-resistant tuberculosis (XDR-TB) and pre-XDR-TB isolates from Ethiopia. Genomic sequencing identifies resistance-associated variants and mycobacterial lineages beyond conventional testing, supporting more effective treatment and enhanced surveillance.
- Getu Diriba
- Hilina Mollalign
- Mesay Hailu Dangisso
